Rheumatology Advance Access originally published online on March 23, 2007
Rheumatology 2007 46(5):885-886; doi:10.1093/rheumatology/kem032
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
LETTERS TO THE EDITOR |
Torquetenovirus in patients with arthritis
1Virology Section and Retrovirus Center, Department of Experimental Pathology, University of Pisa, Pisa, Italy and2Rheumatology Unit, University of Pisa, Pisa, Italy Present Address: S. Specter, Department of Molecular Medicine, University of South Florida, Tampa, FL, USA.
Correspondence to: Mauro Bendinelli. E-mail: bendinelli@biomed.unipi.it
| The first 10% of the full text of this article appears below. |
SIR, Inflammatory joint diseases affect many individuals and can lead to severe disability. Factor(s) and mechanism(s) that lead to joint damage remain elusive. Studies indicate that genetic determinants and environmental factors are important, but that an outside agent possibly initiates pathology [1]. Viruses have been considered as possible aetiological links, but the results remain inconclusive [2].
Torquetenovirus (TTV), one of the three members of the freestanding Anellovirus genus of viruses,